Transcatheter Mitral Valve Repair for the Treatment of Mitral Valve Regurgitation In Heart Failure (The EVOLVE-MR Trial)
Status:
Recruiting
Trial end date:
2024-05-01
Target enrollment:
Participant gender:
Summary
The study compares the effectiveness of treatment with MitraClip to medical therapy in
improving the reduction of cardiovascular morbidity and functional capacity at 24 months, in
patients with moderate functional mitral regurgitation.